
Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience
Elijah
- 0
Acute promyelocytic leukemia is a variant of acute myeloid leukemia characterised by t(15;17) and PML/RAR alfa fusion gene. The invention of the molecular pathogenesis has led to entitle all-trans retinoic acid (ATRA) as the primary focused remedy for acute leukemia. It’s often related to anthracycline-based chemotherapy with excessive response charges, however potential long-term sequelae together with therapy-related malignancies have been noticed.
Arsenic trioxide (ATO) was added to obviate these issues and investigational trials aimed to a brand new technique with the incorporation of arsenic trioxide (ATO) into preliminary remedy as an alternative of chemotherapy in chosen sufferers. ATRA plus ATO with out chemotherapy was the primary try to deal with low and intermediate-risk sufferers with APL. Our examine goals to explain a monocentric cohort of sufferers with newly recognized APL successfully handled with ATO plus ATRA underlying its efficacy along with the excessive grade of tolerability of this affiliation.
From January 2009 to December 2019 23 APL sufferers have been recognized and handled with ATO plus ATRA routine: 14 males and 9 females sufferers with a median age of 45 years (vary 18-72), for almost all intermediate threat (15 sufferers, 65%). The remedy was properly tolerated and all sufferers achieved molecular remission after a median time of three months (vary 1-6 months). All sufferers proceeded to consolidation section as outpatients, they maintained full molecular response at a median time of 44 months (vary 15-127) apart from 1 affected person.
All however one affected person are alive and in response at a median follow-up of 48 months (vary 9-141) with out late results. ATO plus ATRA routine exhibits benefits compared to chemotherapy; actually it allowed to deal with sufferers during which chemotherapy may even not be relevant and it didn’t present secondary hematological ailments. The affiliation of ATO to ATRA as chemo-free routine enabled to deal with APL even with out chemotherapy.
Investigation of the ameliorative results of baicalin in opposition to arsenic trioxide-induced cardiac toxicity in mice
Baicalin (BA), a form of flavonoids compound, comes from Scutellaria baicalensis Georgi (a form of perennial herb) and has useful results on the cardiovascular system by means of anti-oxidant, anti-inflammation, and anti-apoptosis actions. Nevertheless, the therapeutic results and latent mechanisms of BA on arsenic trioxide (ATO)-induced cardiac toxicity has not been reported. The current analysis was carried out to discover the results and mechanisms of BA on ATO-induced coronary heart toxicity.
Male Kunming mice have been handled with ATO (7.5 mg/kg) to induce cardiac toxicity. After the mice obtained ATO, BA (50 and 100 mg/kg) was administered for estimating its cardioprotective results. Statistical information demonstrated that BA remedy alleviated electrocardiogram abnormalities and pathological harm attributable to ATO.
BA may additionally result in restoration of CK and LDH actions to regular vary and trigger a lower in MDA ranges and ROS technology, augmentation of SOD, CAT, and GSH actions. We additionally discovered that BA prompted a discount within the expression of proinflammatory cytokines, akin to TNF-α and IL-6. Furthermore, BA attenuated ATO-induced apoptosis by selling the expression of Bcl-2 and suppressing the expression of Bax and caspase-3. TUNEL take a look at consequence demonstrated BA prompted obstacle of ATO-induced apoptosis.
Moreover, BA remedy suppressed the excessive expression of TLR4, NF-κB and P-NF-κB attributable to ATO. In conclusion, these outcomes point out that BA might alleviate ATO-induced cardiac toxicity by restraining oxidative stress, apoptosis, and irritation, and its mechanism can be related to the inhibition of the TLR4/NF-κB signaling pathway.
Comparative Analysis of Mineral Trioxide Mixture Obturation Utilizing 4 Totally different Methods-A Laboratory Research
This examine aimed to check the density of mineral trioxide combination (MTA) as a root canal filling materials within the apical 5 mm of synthetic root canals. Forty clear acrylic blocks with 30-degree curved canals have been instrumented and allotted into 4 compaction method teams (n = 10): Lawaty (hand recordsdata); gutta-percha (GP) factors; auger (nickel-titanium rotary recordsdata in reverse mode); and plugger method. Crammed canals have been weighed after setting the MTA to calculate distinction in mass.
Two postoperative radiographs in contrast radiopacity by measuring luminance variations at 0.5 mm, 1 mm, 2 mm, Three mm, four mm, and 5 mm from the basis apex. Obturation time was measured utilizing a digital chronometer. The importance stage was set to p < 0.05. The plugger group had a decrease mass. Relative luminance was considerably greater for the Lawaty group than the plugger group in any respect examined apical ranges.
The relative luminance of the auger and GP teams have been considerably greater than the plugger group at depths between 0.5 mm and a couple of mm. Relative luminance was highest for the Lawaty method in any respect depths between 0.5 mm and four mm. The Lawaty method group was related to elevated obturation time in contrast with pluggers. Compacting MTA in curved canals with the Lawaty method has the best mass and radiopacity however requires extra time.

Arsenic trioxide encapsulated liposomes prepared via copper acetate gradient loading method and its antitumor efficiency
In this study, arsenic trioxide (ATO) was encapsulated in liposomes via copper acetate (Cu(OAc)2) gradients and high entrapment efficiency of over 80% was obtained. The average particle size and the zeta-potential of the liposomes were detected to be 115.1 ± 29.1 nm and -21.97 ± 0.6 mV, respectively.
The TEM images showed rod-like precipitates in the inner aqueous phase, which was supposed be due to the formation of insoluble ATO-Cu complex. The in vitro drug release of ATO-Cu liposomes exhibited a sustained release over 72 h, and the release rates decreased with the increase of the pH of release media. Pharmacokinetic and tissue distribution studies of ATO liposomes showed significantly reduced plasma clearance rate, increased AUC0-12 h and T1/2, and improved tumor distribution of As compared to iv administration of ATO solution.
The anti-tumor effect of ATO loaded liposomes to S180 tumor-bearing mice was significantly improved with a tumor inhibition rate of 61.2%, meanwhile the toxicity of encapsulated ATO was greatly decreased.
Molybdenum silicide, 99.5% |
|||
GX2864-250 | Glentham Life Sciences | 250 | EUR 268.8 |
Molybdenum(VI) oxide, 99.9% |
|||
GX8007-100G | Glentham Life Sciences | 100 g | EUR 156 |
Molybdenum(VI) oxide, 99.9% |
|||
GX8007-1KG | Glentham Life Sciences | 1 kg | EUR 466.8 |
Molybdenum(VI) oxide, 99.9% |
|||
GX8007-250G | Glentham Life Sciences | 250 g | EUR 219.6 |
Molybdenum(VI) oxide, 99.0% |
|||
GX6266-250 | Glentham Life Sciences | 250 | EUR 119.1 |
Molybdenum(VI) oxide, 99.0% |
|||
GX6266-500 | Glentham Life Sciences | 500 | EUR 192.2 |
Molybdenum(VI) oxide, 99.9% |
|||
GX8007-1 | Glentham Life Sciences | 1 | EUR 355.8 |
Molybdenum(VI) oxide, 99.9% |
|||
GX8007-100 | Glentham Life Sciences | 100 | EUR 99.7 |
Molybdenum(VI) oxide, 99.9% |
|||
GX8007-250 | Glentham Life Sciences | 250 | EUR 151.8 |
Molybdenum Foil 0.5mm, 99.95% |
|||
GX9163-100 | Glentham Life Sciences | 100 | EUR 231.3 |
Molybdenum(IV) oxide, 99+% |
|||
GX0932-100 | Glentham Life Sciences | 100 | EUR 208.6 |
Molybdenum(IV) oxide, 99+% |
|||
GX0932-25 | Glentham Life Sciences | 25 | EUR 93.4 |
Molybdenum Foil 0.2mm, 99.95% |
|||
GX1246-100 | Glentham Life Sciences | 100 | EUR 164.5 |
Molybdenum Foil 0.3mm, 99.95% |
|||
GX1962-100 | Glentham Life Sciences | 100 | EUR 203.6 |
Molybdenum Foil 0.1mm, 99.95% |
|||
GX2552-100 | Glentham Life Sciences | 100 | EUR 132.6 |
Molybdenum Foil 1.0mm, 99.9+% |
|||
GX9760-100 | Glentham Life Sciences | 100 | EUR 309.6 |
Molybdenum Foil 1.0mm, 99.9+% |
|||
GX9760-150 | Glentham Life Sciences | 150 | EUR 313 |
Molybdenum Sheet 2.5mm, 99.9+% |
|||
GX3862-100 | Glentham Life Sciences | 100 | EUR 301.3 |
Molybdenum Foil 0.15mm, 99.95% |
|||
GX4416-100 | Glentham Life Sciences | 100 | EUR 140.2 |
Molybdenum Sheet 3mm, 99.9+% |
|||
GX6521-100 | Glentham Life Sciences | 100 | EUR 485.6 |
Molybdenum Foil 0.25mm, 99.9+% |
|||
GX8943-100 | Glentham Life Sciences | 100 | EUR 120.5 |
Molybdenum Foil 0.25mm, 99.9+% |
|||
GX8943-150 | Glentham Life Sciences | 150 | EUR 182.5 |
Molybdenum Foil 0.25mm, 99.9+% |
|||
GX8943-50 | Glentham Life Sciences | 50 | EUR 98 |
Molybdenum Sheet 2mm, 99.9+% |
|||
GX9338-100 | Glentham Life Sciences | 100 | EUR 264 |
Molybdenum Sheet 1.5mm, 99.9+% |
|||
GX9615-100 | Glentham Life Sciences | 100 | EUR 215.1 |
Molybdenum Foil 0.025mm, 99.9+% |
|||
GX9911-100 | Glentham Life Sciences | 100 | EUR 177.5 |
Molybdenum Foil 0.025mm, 99.9+% |
|||
GX9911-150 | Glentham Life Sciences | 150 | EUR 220.1 |
Molybdenum Foil 0.025mm, 99.9+% |
|||
GX9911-50 | Glentham Life Sciences | 50 | EUR 104 |
Molybdenum(II) carbide, 99.5+% |
|||
GX1923-100 | Glentham Life Sciences | 100 | EUR 129.6 |
Molybdenum(II) carbide, 99.5+% |
|||
GX1923-250 | Glentham Life Sciences | 250 | EUR 255.7 |
Molybdenum(IV) sulfide, 98+% |
|||
GX2871-1 | Glentham Life Sciences | 1 | EUR 241.2 |
Molybdenum(IV) sulfide, 98+% |
|||
GX2871-250 | Glentham Life Sciences | 250 | EUR 116.1 |
Molybdenum(IV) sulfide, 98+% |
|||
GX2871-500 | Glentham Life Sciences | 500 | EUR 146.2 |
ICP Std Molybdenum 1000ug/mL in H2O |
|||
PMO2C1L | Scientific Laboratory Supplies | 1L | EUR 616.24 |
ICP Std Molybdenum 10000ug/mL in H2O |
|||
RPMO4B7 | Scientific Laboratory Supplies | 250ML | EUR 236.31 |
ICP Std Molybdenum 1000ug/mL in 1% HCl |
|||
PMO2A11 | Scientific Laboratory Supplies | 100ML | EUR 134.48 |
ICP Std Molybdenum 1000ug/mL in 2% NH4OH |
|||
PMO2B7 | Scientific Laboratory Supplies | 250ML | EUR 213.6 |
ICP Std Molybdenum 1000ug/mL in 2% NH4OH |
|||
PMO2C7 | Scientific Laboratory Supplies | 500ML | EUR 386.46 |
ICP Std Molybdenum 10000ug/mL in 2% NH4OH |
|||
PMO4A7 | Scientific Laboratory Supplies | 100ML | EUR 231.09 |
ICP Std Molybdenum 10000ug/mL in 3.5% NH4OH |
|||
PMO4B4-500ML | Scientific Laboratory Supplies | 500ML | EUR 923.06 |
ICP Std Molybdenum 100ug/mL in 2% NH4OH |
|||
PMO1A7 | Scientific Laboratory Supplies | 100ML | EUR 236.31 |
ICP Std Molybdenum 100ug/mL in 2% NH4OH |
|||
PMO1C3 | Scientific Laboratory Supplies | 500ML | EUR 364.26 |
AAS Molybdenum Std 1000ppm in H2O |
|||
AAMOH | Scientific Laboratory Supplies | 500ML | EUR 106.8 |
AAS Molybdenum Std 10000ppm in H2O |
|||
AAMOM | Scientific Laboratory Supplies | 500ML | EUR 338.4 |
Molybdenum Rod 6.0 mm diameter, 99.9+% |
|||
GX4022-250 | Glentham Life Sciences | 250 | EUR 167.9 |
Molybdenum Rod 4.0 mm diameter, 99.9+% |
|||
GX5235-250 | Glentham Life Sciences | 250 | EUR 120.5 |
Molybdenum Rod 4.0 mm diameter, 99.9+% |
|||
GX5235-500 | Glentham Life Sciences | 500 | EUR 163 |
Molybdenum Rod 3.0 mm diameter, 99.9+% |
|||
GX6474-500 | Glentham Life Sciences | 500 | EUR 107 |
Molybdenum Rod 1 mm diameter, 99.95% |
|||
GX7974-1 | Glentham Life Sciences | 1 | EUR 105.5 |
Molybdenum Rod 2.0 mm diameter, 99.9+% |
|||
GX8666-1 | Glentham Life Sciences | 1 | EUR 164.5 |
Molybdenum Rod 2.0 mm diameter, 99.9+% |
|||
GX8666-500 | Glentham Life Sciences | 500 | EUR 102.4 |
Molybdenum Rod 10 mm diameter, 99.95% |
|||
GX8980-100 | Glentham Life Sciences | 100 | EUR 179.3 |
Molybdenum Rod 10 mm diameter, 99.95% |
|||
GX8980-250 | Glentham Life Sciences | 250 | EUR 332.3 |
Molybdenum Rod 12 mm diameter, 99.9+% |
|||
GX0906-100 | Glentham Life Sciences | 100 | EUR 210.1 |
Molybdenum Rod 5.0 mm diameter, 99.95% |
|||
GX1673-100 | Glentham Life Sciences | 100 | EUR 114.5 |
Molybdenum Rod 5.0 mm diameter, 99.95% |
|||
GX1673-250 | Glentham Life Sciences | 250 | EUR 160.5 |
Molybdenum Rod 5.0 mm diameter, 99.95% |
|||
GX1673-500 | Glentham Life Sciences | 500 | EUR 269.6 |
Molybdenum Rod 20 mm diameter, 99.9+% |
|||
GX2933-100 | Glentham Life Sciences | 100 | EUR 303.1 |
Molybdenum Rod 20 mm diameter, 99.9+% |
|||
GX2933-500 | Glentham Life Sciences | 500 | EUR 1165.9 |
Molybdenum Rod 2.5 mm diameter, 99.9+% |
|||
GX3152-500 | Glentham Life Sciences | 500 | EUR 105.5 |
Molybdenum Rod 8.0 mm diameter, 99.9+% |
|||
GX3370-250 | Glentham Life Sciences | 250 | EUR 241.2 |
Molybdenum Rod 1.5 mm diameter, 99.95% |
|||
GX9336-1 | Glentham Life Sciences | 1 | EUR 135.6 |
Molybdenum Rod 30 mm diameter, 99.9+% |
|||
GX9467-100 | Glentham Life Sciences | 100 | EUR 536.1 |
Molybdenum Pellets 6 x 12 mm, 99.9+% |
|||
GX2699-100 | Glentham Life Sciences | 100 | EUR 198.7 |
Molybdenum Pellets 6 x 12 mm, 99.9+% |
|||
GX2699-25 | Glentham Life Sciences | 25 | EUR 99.4 |
Molybdenum Powder, 2-5 micron, 99.95+% |
|||
GX4223-100 | Glentham Life Sciences | 100 | EUR 99.4 |
Molybdenum Powder, 2-5 micron, 99.95+% |
|||
GX4223-500 | Glentham Life Sciences | 500 | EUR 277.1 |
Molybdenum Wire 1.0 mm diameter, 99.95% |
|||
GX4703-25 | Glentham Life Sciences | 25 | EUR 290 |
Molybdenum Wire 1.0 mm diameter, 99.95% |
|||
GX4703-5 | Glentham Life Sciences | 5 | EUR 119.1 |
Molybdenum Wire 0.3 mm diameter, 99.95% |
|||
GX7025-100 | Glentham Life Sciences | 100 | EUR 228.1 |
Molybdenum Wire 0.3 mm diameter, 99.95% |
|||
GX7025-25 | Glentham Life Sciences | 25 | EUR 111.5 |
Molybdenum Wire 0.25 mm diameter, 99.95% |
|||
GX7146-100 | Glentham Life Sciences | 100 | EUR 184.1 |
Molybdenum Wire 0.25 mm diameter, 99.95% |
|||
GX7146-25 | Glentham Life Sciences | 25 | EUR 96.4 |
Molybdenum Wire 0.7 mm diameter, 99.95% |
|||
GX7237-10 | Glentham Life Sciences | 10 | EUR 105.5 |
Molybdenum Wire 0.7 mm diameter, 99.95% |
|||
GX7237-25 | Glentham Life Sciences | 25 | EUR 177.5 |
Molybdenum Wire 0.1 mm diameter, 99.95% |
|||
GX7396-100 | Glentham Life Sciences | 100 | EUR 125.1 |
Molybdenum Wire 0.1 mm diameter, 99.95% |
|||
GX7396-50 | Glentham Life Sciences | 50 | EUR 90.4 |
Molybdenum Wire 2.0 mm diameter, 99.95% |
|||
GX0175-1 | Glentham Life Sciences | 1 | EUR 126.5 |
Molybdenum Wire 2.0 mm diameter, 99.95% |
|||
GX0175-5 | Glentham Life Sciences | 5 | EUR 314.4 |
Molybdenum Wire 1.5 mm diameter, 99.95% |
|||
GX0574-1 | Glentham Life Sciences | 1 | EUR 99.4 |
Molybdenum Wire 1.5 mm diameter, 99.95% |
|||
GX0574-5 | Glentham Life Sciences | 5 | EUR 224.9 |
Molybdenum Wire 0.5 mm diameter, 99.95% |
|||
GX3073-100 | Glentham Life Sciences | 100 | EUR 382.9 |
Molybdenum Wire 0.5 mm diameter, 99.95% |
|||
GX3073-25 | Glentham Life Sciences | 25 | EUR 147.6 |
Molybdenum Powder max. 100 micron, 99.9% |
|||
GX3538-100 | Glentham Life Sciences | 100 | EUR 123.5 |
Molybdenum Powder max. 100 micron, 99.9% |
|||
GX3538-500 | Glentham Life Sciences | 500 | EUR 303.1 |
ICP Std Molybdenum 1000ug/mL in 2-5% HNO3 tr. HF |
|||
PMO2A10 | Scientific Laboratory Supplies | 100ML | EUR 246.76 |
ICP Standard Molybdenum H2O 1000ug/ml |
|||
PMO2A7 | Scientific Laboratory Supplies | 100ML | EUR 132 |
Molybdenum Foil 0.1 mm, plane, shiny, 99.95% |
|||
GX4593-100 | Glentham Life Sciences | 100 | EUR 180.9 |
Molybdenum(IV) disulfide Nanopowder, 99 % |
|||
GX4987-10 | Glentham Life Sciences | 10 | EUR 311.3 |
Molybdenum(IV) disulfide Nanopowder, 99 % |
|||
GX4987-25 | Glentham Life Sciences | 25 | EUR 593.2 |
Molybdenum Cofactor Synthesis 2 Protein |
|||
20-abx263321 | Abbexa |
|
|
Molybdenum Cofactor Sulfurase (MOCOS) Antibody |
|||
abx235263-100ug | Abbexa | 100 ug | EUR 577.2 |
Molybdenum Cofactor Sulfurase (MOCOS) Antibody |
|||
20-abx113870 | Abbexa |
|
|
Arsenic Trioxide Standard 100ppm |
|||
AR2O3-CO | Scientific Laboratory Supplies | 1L | EUR 266.4 |
SULFUR TRIOXIDE PYRIDINE COMPLEX |
|||
719008 | Survival Technologies | each | Ask for price |
Molybdenum 1000 ug/g (1000 PPM) for AA and ICP 50 grams in Base Oil 75 |
|||
ORG-MO8-2Z | Scientific Laboratory Supplies | 50G | EUR 70.8 |
Molybdenum 5000 ug/g (5000 PPM) for AA and ICP 50 grams in Base Oil 75 |
|||
ORG-MO8-4Z | Scientific Laboratory Supplies | 50G | EUR 85.2 |
Molybdenum Pellets‚6.35 x 6.35 mm, vacuum melted, 99.98% |
|||
GX9003-100 | Glentham Life Sciences | 100 | EUR 293.3 |
Molybdenum Pellets‚6.35 x 6.35 mm, vacuum melted, 99.98% |
|||
GX9003-25 | Glentham Life Sciences | 25 | EUR 119.1 |
Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody |
|||
abx235264-100ug | Abbexa | 100 ug | EUR 577.2 |
Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody |
|||
20-abx113871 | Abbexa |
|
|
Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody |
|||
20-abx322547 | Abbexa |
|
|
Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody |
|||
20-abx321401 | Abbexa |
|
|
Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody |
|||
20-abx321402 | Abbexa |
|
|
Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody |
|||
20-abx321947 | Abbexa |
|
|
Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody |
|||
abx036894-100ug | Abbexa | 100 ug | EUR 469.2 |
Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody |
|||
abx037731-100ug | Abbexa | 100 ug | EUR 469.2 |
Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody |
|||
20-abx005887 | Abbexa |
|
|
Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody |
|||
20-abx135733 | Abbexa |
|
|
Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody |
|||
20-abx131326 | Abbexa |
|
|
Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody |
|||
20-abx131327 | Abbexa |
|
|
Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody |
|||
20-abx304514 | Abbexa |
|
|
Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody |
|||
abx028710-400ul | Abbexa | 400 ul | EUR 627.6 |
Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody |
|||
abx028710-80l | Abbexa | 80 µl | EUR 343.2 |
Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody |
|||
abx025653-400ul | Abbexa | 400 ul | EUR 627.6 |
Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody |
|||
abx025653-80l | Abbexa | 80 µl | EUR 343.2 |
Kinesis Hollow Cathode Lamp Molybdenum 37mm Std |
|||
CHR5781 | Scientific Laboratory Supplies | EACH | EUR 334.23 |
Cow Molybdenum cofactor sulfurase (MOCOS) ELISA Kit |
|||
abx516487-96tests | Abbexa | 96 tests | EUR 1093.2 |
ELISA kit for Human Molybdenum cofactor sulfurase |
|||
EK3232 | SAB | 96 tests | EUR 663.6 |
Description: Enzyme-linked immunosorbent assay kit for quantification of Human Molybdenum cofactor sulfurase in samples from serum, plasma, tissue homogenates and other biological fluids. |
Recombinant Molybdenum Cofactor Synthesis 1 (MOCS1) |
|||
4-RPC623Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Molybdenum Cofactor Synthesis 1 expressed in: E.coli |
Recombinant Molybdenum Cofactor Synthesis 1 (MOCS1) |
|||
4-RPC623Mu01 | Cloud-Clone |
|
|
Description: Recombinant Mouse Molybdenum Cofactor Synthesis 1 expressed in: E.coli |
Kinesis Hollow Cathode Lamp Molybdenum 37mm unicam |
|||
CHR5785 | Scientific Laboratory Supplies | EACH | EUR 385.15 |
Kinesis Hollow Cathode Lamp Molybdenum 37mm Varian |
|||
CHR5787 | Scientific Laboratory Supplies | EACH | EUR 385.15 |
Mouse Molybdenum cofactor sulfurase (MOCOS) ELISA Kit |
|||
abx516489-96tests | Abbexa | 96 tests | EUR 886.8 |
Mouse Mocos/ Molybdenum cofactor sulfurase ELISA Kit |
|||
E0967Mo | Sunlong | 1 Kit | EUR 758.4 |
Human MOCOS/ Molybdenum cofactor sulfurase ELISA Kit |
|||
E1626Hu | Sunlong | 1 Kit | EUR 726 |
Mouse Molybdenum cofactor sulfurase, Mocos ELISA KIT |
|||
ELI-16543m | Lifescience Market | 96 Tests | EUR 1038 |
Human Molybdenum cofactor sulfurase, MOCOS ELISA KIT |
|||
ELI-20833h | Lifescience Market | 96 Tests | EUR 988.8 |
Human Molybdenum cofactor sulfurase (MOCOS) ELISA Kit |
|||
abx250798-96tests | Abbexa | 96 tests | EUR 801.6 |
Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody (HRP) |
|||
20-abx304515 | Abbexa |
|
|
Human MOCOS(Molybdenum cofactor sulfurase) ELISA Kit |
|||
EH1514 | FN Test | 96T | EUR 681.12 |
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.188 ng/ml |
Kinesis Hollow Cathode Lamp Molybdenum 50mm Standard |
|||
CHR5789 | Scientific Laboratory Supplies | EACH | EUR 438.68 |
Bovine Molybdenum cofactor sulfurase, MOCOS ELISA KIT |
|||
ELI-19415b | Lifescience Market | 96 Tests | EUR 1113.6 |
Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody (FITC) |
|||
20-abx304516 | Abbexa |
|
|
Human Molybdenum Cofactor Synthesis 1 (MOCS1) Protein |
|||
20-abx650079 | Abbexa |
|
|
Mouse Molybdenum Cofactor Synthesis 1 (MOCS1) Protein |
|||
20-abx650080 | Abbexa |
|
|
Bovine MOCOS/ Molybdenum cofactor sulfurase ELISA Kit |
|||
E0183Bo | Sunlong | 1 Kit | EUR 860.4 |
Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody (Biotin) |
|||
20-abx304517 | Abbexa |
|
|
Human Molybdenum Cofactor Synthesis 2 (MOCS2) ELISA Kit |
|||
abx381488-96tests | Abbexa | 96 tests | EUR 1093.2 |
SULFUR TRIOXIDE DIMETHYL FORMAMIDE COMPLEX |
|||
919007 | Survival Technologies | each | Ask for price |
USP Stock Sol. to make Arsenic Trioxide |
|||
USP6701 | Scientific Laboratory Supplies | 100ML | EUR 124.8 |
USP Stock Sol. to make Arsenic Trioxide |
|||
USP6705 | Scientific Laboratory Supplies | 500ML | EUR 517.2 |
Mocos ELISA Kit| Mouse Molybdenum cofactor sulfurase ELISA Kit |
|||
EF015558 | Lifescience Market | 96 Tests | EUR 826.8 |
Kinesis Hollow Cathode Lamp Molybdenum 50mm PE AAnalyst (Lumina) |
|||
CHR5791 | Scientific Laboratory Supplies | EACH | EUR 567.94 |
MOCOS ELISA Kit| Bovine Molybdenum cofactor sulfurase ELISA Kit |
|||
EF011614 | Lifescience Market | 96 Tests | EUR 826.8 |
Assurance Grade Molybdenum for AA and ICP 1000 ug/mL (1000 PPM) 30mL in H2O |
|||
PLMO9-2M | Scientific Laboratory Supplies | 30ML | EUR 34.8 |
×
In conclusion, ATO can be effectively encapsulated into liposomes by remote loading method via Cu(OAc)2 gradients; the co-administration of ATO and Cu(II) via liposomal formulation may find wide applications in the treatment of various tumors.
Tags: blasticidin resistance gene camkv antibody dna alsace dna ancestry dna definition dna h&r block dna meaning dna molecule dna painter dna polymerase dna replication dna testing dna vs rna dnase maxiprep kit pcdna3 vector map peptide biosynthesis peptide bond define peptide bond definition peptide collagen peptide eye cream peptide linkage peptide linker peptide nad peptide pond peptide prediction peptide test peptide volume essence review peptide volume essence webtretho peptide volume lifting essence peptide volume tox essence peptides for aging peptides for anti-aging peptides for bodybuilding peptides for muscle peptides in foods peptides meaning pet vector